PERSON DIRECTORY
Allison DeAngelis
Allison DeAngelis appears in 2 indexed conversations across Biotech Hangout. This directory brings every appearance, source, TL;DR, digest, and transcript into one searchable feed.
2 EPISODES1 SHOW
Language
Episode 182 - May 8, 2026
Josh SchimmerPaul MatteisEric SchmidtYaron WerberAllison DeAngelis
Record biotech secondaries are following better-than-expected data, while Angelini’s $4.1B Catalyst deal and UCB’s $2B-upfront Candid acquisition signal renewed dealmaking.Capital favors development stories over commercial biotech, while Agios’s thalassemia launch may leave 2026 consensus threefold too low and FDA turmoil keeps regulatory credibility in focus.